1. Preface

   • Akira Matsuno

   Preface 23 July 2021 Pages: 147 - 148

2. Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy

   • Eiichi Ishikawa
   • Tsubasa Miyazaki
   • Hiroyoshi Akutsu

   Review Article 11 May 2021 Pages: 149 - 155

   

3. Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options

   • Chaoying Qin
   • Meng Huang
   • Qing Liu

   Review Article 26 April 2021 Pages: 156 - 172

   

4. Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development

   • Kensuke Tateishi
   • Yohei Miyake
   • Tetsuya Yamamoto

   Review Article 13 July 2021 Pages: 173 - 182

   

5. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms

   • Chie Inomoto
   • Shigeyuki Tahara
   • Robert Y. Osamura

   Review Article 16 July 2021 Pages: 183 - 188

   

6. Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia

   • Weiqi Dang
   • Jingfang Xiao
   • Xiuwu Bian

   Original Article 06 July 2021 Pages: 189 - 200

   

7. Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma

   • Jun-ichi Adachi
   • Mitsuaki Shirahata
   • Ryo Nishikawa

   Original Article 14 June 2021 Pages: 201 - 209

   

8. Clinical implications of molecular analysis in diffuse glioma stratification

   • Masahiro Mizoguchi
   • Nobuhiro Hata
   • Toru Iwaki

   Original Article 15 July 2021 Pages: 210 - 217

   

9. Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma

   • Yoshinari Osada
   • Ryuta Saito
   • Teiji Tominaga

   Original Article 16 July 2021 Pages: 218 - 227

   

10. Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features

    • Manabu Natsumeda
    • Michael Chang
    • Karisa C. Schreck

    Original Article 03 July 2021 Pages: 228 - 233

    

11. Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes

    • Zhicen Li
    • Yifan Wei
    • Jian Gong

    Original Article 28 June 2021 Pages: 234 - 242

    

12. Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence

    • Masaki Ujihara
    • Kazuhiko Mishima
    • Ryo Nishikawa

    Case Report 28 April 2021 Pages: 243 - 249

    

13. A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication

    • Taku Uchiyama
    • Akira Gomi
    • Kensuke Kawai

    Case Report 09 April 2021 Pages: 250 - 256

    

14. Metabolic, immunohistochemical, and genetic profiling of a cerebellar liponeurocytoma with spinal dissemination: a case report and review of the literature

    • Seiichiro Hirono
    • Yue Gao
    • Yasuo Iwadate

    Case Report 17 June 2021 Pages: 257 - 262

    

15. A case of central nervous system lesion pathologically characterized by angiocentric, T-cell-rich lymphoid cell infiltrates: a case report and literature review

    • Ryotaro Imai
    • Hanako Tsujikawa
    • Hikaru Sasaki

    Case Report 30 March 2021 Pages: 263 - 270